Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuki Hatayama

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Acta Crystallographica. Section E, Structure Reports Online|January 20, 2012
9-[(E)-2-(4,4,5,5-Tetra-methyl-1,3,2-dioxa-borolan-2-yl)ethen-yl]-9H-carbazoleYuki Hatayama, Tsunehisa Okuno
Iucrdata|November 7, 2022
<i>N</i>-Phenyl-<i>N</i>-[(<i>E</i>)-2-(4,4,5,5-tetra-methyl-1,3,2-dioxaborolan-2-yl)ethen-yl]anilineYuki Hatayama, Kazuto Akagi, Tsunehisa Okuno
The Journal of International Medical Research|November 30, 2020
Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapyYuki Hatayama, Yuki Hashimoto, Toru Motokura
Yonago Acta Medica|October 7, 2016
Construction and Evaluation of Cytomegalovirus DNA Quantification System with Real-Time Detection Polymerase Chain ReactionYuki Hatayama, Yuki Hashimoto, Ayako Hara, et al.
European Journal of Pharmacology|December 3, 2014
Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated miceTakashi Hashimoto, Yuki Hatayama, Keiko Nakamichi, et al.
Yonago Acta Medica|September 5, 2022
Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform AnalysisKonami Kato, Yuki Hatayama, Hisashi Shimohiro, et al.
Molecular Medicine Reports|September 1, 2023
Serum levels of vault RNA significantly varied in patients with haematological malignanciesHaruka Kato, Yuki Hashimoto, Yuki Hatayama, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 12, 2024
Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19Takuya Iwamoto, Yuki Hatayama, Noriko Yamashita, et al.
Molecular and Cellular Probes|February 9, 2025
Serum vault RNA1-1 levels reflect blood cells and bone marrowYuki Hatayama, Hisashi Shimohiro, Yuki Hashimoto, et al.
Viral Immunology|July 13, 2023
Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell LymphomaYuki Hatayama, Kanako Watanabe, Hitomi Ichikawa, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Acta Crystallographica. Section E, Structure Reports Online|January 20, 2012
9-[(E)-2-(4,4,5,5-Tetra-methyl-1,3,2-dioxa-borolan-2-yl)ethen-yl]-9H-carbazoleYuki Hatayama, Tsunehisa Okuno
Iucrdata|November 7, 2022
<i>N</i>-Phenyl-<i>N</i>-[(<i>E</i>)-2-(4,4,5,5-tetra-methyl-1,3,2-dioxaborolan-2-yl)ethen-yl]anilineYuki Hatayama, Kazuto Akagi, Tsunehisa Okuno
The Journal of International Medical Research|November 30, 2020
Frequent co-reactivation of Epstein-Barr virus in patients with cytomegalovirus viremia under immunosuppressive therapy and/or chemotherapyYuki Hatayama, Yuki Hashimoto, Toru Motokura
Yonago Acta Medica|October 7, 2016
Construction and Evaluation of Cytomegalovirus DNA Quantification System with Real-Time Detection Polymerase Chain ReactionYuki Hatayama, Yuki Hashimoto, Ayako Hara, et al.
European Journal of Pharmacology|December 3, 2014
Procognitive effect of AC-3933 in aged mice, and synergistic effect of combination with donepezil in scopolamine-treated miceTakashi Hashimoto, Yuki Hatayama, Keiko Nakamichi, et al.
Yonago Acta Medica|September 5, 2022
Differences in the Composition of Activated Partial Thromboplastin Time (APTT) Reagents Affect Clot Waveform AnalysisKonami Kato, Yuki Hatayama, Hisashi Shimohiro, et al.
Molecular Medicine Reports|September 1, 2023
Serum levels of vault RNA significantly varied in patients with haematological malignanciesHaruka Kato, Yuki Hashimoto, Yuki Hatayama, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 12, 2024
Association Between Coagulation Fibrinolysis Markers and Severity in Patients with COVID-19Takuya Iwamoto, Yuki Hatayama, Noriko Yamashita, et al.
Molecular and Cellular Probes|February 9, 2025
Serum vault RNA1-1 levels reflect blood cells and bone marrowYuki Hatayama, Hisashi Shimohiro, Yuki Hashimoto, et al.
Viral Immunology|July 13, 2023
Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell LymphomaYuki Hatayama, Kanako Watanabe, Hitomi Ichikawa, et al.
Pageof 2